
'I was maimed by the NHS and left to wait - this is the reality for mesh victims'
Nancy Honeyball, from Dunoon, had the implant fitted in 2010 due to bladder problems and says she has been 'plagued' with complications ever since.
She is among many mesh-injured women who say they are still being failed by the Scottish Government.
Nancy travelled to Missouri in the US for removal surgery with renowned mesh specialist Dr Dionysios Veronikis in March 2024 under a scheme funded by the Scottish Government. She had hoped the operation would finally be the end of her ordeal.
She said Dr Veronikis was 'shocked' to learn of her experiences.
'His words were 'if that had happened in America, there would be a lawsuit,'' Nancy told STV News.
'He's had a look as a professional and been quite upset at how they've been left. He looked at me and he said an animal would be treated better,' she said.
'I'm grateful I managed to get on the list to go to America, but I wouldn't go as far as to say 'thank you very much.' The NHS maimed me – and thousands of others – all to save money. It's always been profit over health, and it's wrong.
'I don't trust the surgeons in Scotland – that's why I fought to go to the USA.' STV News
In the year since her operation, Nancy said she had no check-ups or calls from the NHS.
She added: 'Even Dr Veronikis has been in touch numerous times to check how I am, but nobody from the NHS in Scotland has. I feel, after the way I was treated in Glasgow, that I'm blacklisted, and that's why I'm having to fight so hard to get things done. It's wrong.'
Nancy underwent her first surgery to remove a transvaginal mesh implant in London in 2017, but it was unsuccessful and failed to resolve her chronic pain.
In 2019, she had a second surgery in England to remove the mesh arms. Despite making it clear that she did not want any more plastic implanted, Nancy was horrified to discover that plastic sutures had been used.
Her complaint about this was upheld by the General Medical Council in October 2024. The surgeon involved was suspended for nine months.
Dr Veronikis successfully removed Nancy's remaining mesh in March 2024, but was unable to take out the sutures due to limits in the Scottish Government's contract, which covered only mesh removal, not full pelvic repair.
Back in Scotland, Nancy was referred to Crosshouse Hospital in Kilmarnock. However, she received a letter from NHS Ayrshire & Arran informing her she would face a 92-week wait for further treatment.
'I had a total meltdown. I had a panic attack.. Because it's just too much. Why should a patient have to chase and chase follow‑ups? It's ridiculous.
'People might think, 'who do you think you are? Everyone else has to wait.' When you've waited and fought for nearly 15 years – that's how long I've been plagued by this – I wish I could turn the clock back.
'If I'd seen the device they use, I'd never have gone with anything. I'd say 'no thank you – I'll stay how I am.'
'But you trust the doctors. We were told it's a gold standard operation, and you'd be in and out the same day. It would change your life forever. It certainly did; it changed my life for the worse, not the better.'
Over two decades, more than 20,000 women in Scotland had transvaginal mesh implants to treat post-childbirth conditions, like incontinence and prolapse.
Its use was stopped in 2014 after hundreds of women were left with painful, life-altering complications.
In 2021, then health secretary Humza Yousaf, announced contracts for mesh patients to undergo removal surgery from Dr Veronikis in Missouri or Spire Health Care in Bristol through the National Mesh Removal Referral Pathway.
Figures show that 64 patients have now travelled to independent providers in England or the United States for mesh removal surgery, at a cost of around £2m to the Scottish Government.
Since April 2020, 339 patients have been referred to the Complex Mesh Surgical Service in Glasgow and 161 have undergone surgery.
A spokesperson for NHS Greater Glasgow and Clyde said that while some of the remaining patients may still be undergoing assessment, the majority are either receiving conservative (non-surgical) treatment, have opted not to proceed with surgery, or were found not to require it.
A separate £1m fund was set up to offer women a one-off payment of £1,000 to help towards the costs associated with emotional or practical support.
Nancy branded the fund 'a slap in the face' and said a full redress scheme is needed.
'There are so many things mesh has affected – loss of jobs, houses, marriages, relationships. People are left to fend for themselves,' she said.
'To me, everything should be covered. The NHS maimed us – it's the biggest scandal since Thalidomide and the blood scandal. Nobody has been brought to justice. I don't understand.'
Nancy now has an appointment scheduled for next month, but she remains in pain and emotionally exhausted.
'It's been a constant rollercoaster, emotions up and down. Some days I totally break down. I'm a strong, independent person – I'll be laughing and joking, but it's just a mask.
'People will say, 'I don't know how you're still standing' – but I've got to keep fighting. Even though I just want to give up. I keep going.' STV News
Women's health minister Jenni Minto said she has been working closely with Scottish Government teams to improve support and aftercare for those affected.
She said: 'It's important to recognise the Scottish Government has supported women to allow them to get their mesh removed. I do appreciate that some women have not had the right support once that has happened.
'We expect the local health boards to take that responsibility and look after women. Because after having had that treatment, the best place to continue the support and the ways that they can improve the way they're living their lives is as locally as possible. I expect local health boards will be doing that.
'I'm working very closely with NHS Education for Scotland (NES) to ensure that is spread out across health boards so they do recognise the importance of that.
'But I also think we have to recognise this is quite a complicated situation and, therefore, we need multi-disciplinary teams and the right ones in the right place to be able to support women to heal – and hopefully return to a better life.'
NHS Ayrshire & Arran has been contacted for comment.
Get all the latest news from around the country Follow STV News
Scan the QR code on your mobile device for all the latest news from around the country

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


South Wales Guardian
an hour ago
- South Wales Guardian
Pharmacies warn of unsustainable demand for weight loss medication
Many more patients are interested in using weight loss medication than are actually suitable for treatment, according to the National Pharmacy Association (NPA), which represents more than 6,000 independent community pharmacies. Some 21% of people who were interviewed in a NPA-commissioned poll agreed they had attempted to access weight loss treatments in the last year, either online or in person at a pharmacy, rising to 35% of 16 to 34-year-olds. This is compared to only 7% of those over 55. There were also 41% who agreed they would opt for weight loss treatments on the NHS if they were made available to them. This figure rose to 64% among 25 to 34-year-olds, despite many of these patients being unlikely to be clinically eligible. The NPA says the poll, in which 2,002 people were interviewed, reflects an increasing demand for private and NHS weight loss services. NPA chairman Olivier Picard said: 'Weight loss jabs are one of the biggest drug innovations this century, but growing demand for weight loss treatment highlights the need to make sure this is appropriate for those who want it. 'It's clear from this polling that many more people are interested in getting weight loss jabs than would actually be suitable for treatment. 'We want to make sure supplies are carefully managed so that those in most clinical need can benefit from weight loss medication.' Spiralling demand, fuelled partly by social media, could see people being tempted to resort to unregulated online suppliers instead of regulated pharmacies staffed by medical professionals, they fear. Online suppliers may not be offering weight loss jabs alongside a structured programme aimed at helping them change their behaviour. Wegovy and Mounjaro are among a number of drugs that are recommended to help tackle obesity on the NHS. Mounjaro and Wegovy are licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) for use in patients with a BMI of over 30 or between 27 and 30 but with a weight-related co-morbidity. This occurs when an individual who has obesity develops another medical condition due to their weight. The NHS currently rolls out Mounjaro to patients with a BMI of over 40 and at least four co-morbidities, the NPA says. The NPA is calling for new regulations to protect patients buying weight loss medication online, so there is a full two-way consultation and all relevant historical medical records are reviewed before the treatment is prescribed. They are waiting for more details about the role pharmacies could play in the rollout of the NHS weight management programme. At least 85% of weight loss medication prescriptions were made by pharmacies in April this year, the NPA estimates. Mr Picard said: 'Pharmacists are experts in medication and many have extensive experience delivering weight loss injections as part of a package of care, including lifestyle advice. 'Pharmacies are well placed to help roll this treatment out on the NHS, and help people make the best use of these powerful medicines.'


Times
2 hours ago
- Times
I was a Gen Z screen addict. Then I took drastic action
A lot can happen in seven hours. You could fly from London to Dubai, get through a full school day or enjoy a luxurious night's sleep. Me? I used to spend seven hours a day staring at my phone screen. Now I average less than one. I'm 22 and I've spent an alarming percentage of my life glued to my phone. It was everything — my entertainment, my social lifeline, my procrastination tool, my 3am therapist. I'm far from alone. Data shows that Generation Z's daily screen time is on average more than nine hours a day, which is more than any other generation. That's about 136 days a year spent staring at a screen. Meanwhile, the NHS reports a steep rise in mental health disorders among young people, which tracks closely with the explosion in digital device use.

Leader Live
2 hours ago
- Leader Live
Pharmacies warn of unsustainable demand for weight loss medication
Many more patients are interested in using weight loss medication than are actually suitable for treatment, according to the National Pharmacy Association (NPA), which represents more than 6,000 independent community pharmacies. Some 21% of people who were interviewed in a NPA-commissioned poll agreed they had attempted to access weight loss treatments in the last year, either online or in person at a pharmacy, rising to 35% of 16 to 34-year-olds. This is compared to only 7% of those over 55. There were also 41% who agreed they would opt for weight loss treatments on the NHS if they were made available to them. This figure rose to 64% among 25 to 34-year-olds, despite many of these patients being unlikely to be clinically eligible. The NPA says the poll, in which 2,002 people were interviewed, reflects an increasing demand for private and NHS weight loss services. NPA chairman Olivier Picard said: 'Weight loss jabs are one of the biggest drug innovations this century, but growing demand for weight loss treatment highlights the need to make sure this is appropriate for those who want it. 'It's clear from this polling that many more people are interested in getting weight loss jabs than would actually be suitable for treatment. 'We want to make sure supplies are carefully managed so that those in most clinical need can benefit from weight loss medication.' Spiralling demand, fuelled partly by social media, could see people being tempted to resort to unregulated online suppliers instead of regulated pharmacies staffed by medical professionals, they fear. Online suppliers may not be offering weight loss jabs alongside a structured programme aimed at helping them change their behaviour. Wegovy and Mounjaro are among a number of drugs that are recommended to help tackle obesity on the NHS. Mounjaro and Wegovy are licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) for use in patients with a BMI of over 30 or between 27 and 30 but with a weight-related co-morbidity. This occurs when an individual who has obesity develops another medical condition due to their weight. The NHS currently rolls out Mounjaro to patients with a BMI of over 40 and at least four co-morbidities, the NPA says. The NPA is calling for new regulations to protect patients buying weight loss medication online, so there is a full two-way consultation and all relevant historical medical records are reviewed before the treatment is prescribed. They are waiting for more details about the role pharmacies could play in the rollout of the NHS weight management programme. At least 85% of weight loss medication prescriptions were made by pharmacies in April this year, the NPA estimates. Mr Picard said: 'Pharmacists are experts in medication and many have extensive experience delivering weight loss injections as part of a package of care, including lifestyle advice. 'Pharmacies are well placed to help roll this treatment out on the NHS, and help people make the best use of these powerful medicines.'